Cargando…

Impact of treating iron deficiency, diagnosed according to hepcidin quantification, on outcomes after a prolonged ICU stay compared to standard care: a multicenter, randomized, single-blinded trial

BACKGROUND: Anemia is a significant problem in patients on ICU. Its commonest cause, iron deficiency (ID), is difficult to diagnose in the context of inflammation. Hepcidin is a new marker of ID. We aimed to assess whether hepcidin levels would accurately guide treatment of ID in critically ill anem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasocki, Sigismond, Asfar, Pierre, Jaber, Samir, Ferrandiere, Martine, Kerforne, Thomas, Asehnoune, Karim, Montravers, Philippe, Seguin, Philippe, Peoc’h, Katell, Gergaud, Soizic, Nagot, Nicolas, Lefebvre, Thibaud, Lehmann, Sylvain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885380/ https://www.ncbi.nlm.nih.gov/pubmed/33588893 http://dx.doi.org/10.1186/s13054-020-03430-3

Ejemplares similares

Iron deficiency in critically ill patients: highlighting the role of hepcidin
por: Heming, Nicholas, et al.
Publicado: (2011)

Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
por: Touzot, Maxime, et al.
Publicado: (2021)

Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients
por: Lasocki, Sigismond, et al.
Publicado: (2018)

ORI monitoring allows a reduction of time with hyperoxia in critically ill patients: the randomized control ORI(2) study
por: Lasocki, Sigismond, et al.
Publicado: (2019)

Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study
por: Lasocki, Sigismond, et al.
Publicado: (2014)

Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors
por: Blet, Alice, et al.
Publicado: (2022)

Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory Diseases
por: Cacoub, Patrice, et al.
Publicado: (2022)

Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action
por: Cacoub, Patrice, et al.
Publicado: (2022)

Risk factors for therapeutic failure in the management of post-operative peritonitis: a post hoc analysis of the DURAPOP trial
por: Montravers, Philippe, et al.
Publicado: (2021)

Population pharmacokinetic/pharmacodynamic study suggests continuous infusion of ceftaroline daily dose in ventilated critical care patients with early-onset pneumonia and augmented renal clearance
por: Chauzy, Alexia, et al.
Publicado: (2022)

Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study
por: Lasocki, Sigismond, et al.
Publicado: (2008)

Iron deficiency markers in patients undergoing iron replacement therapy: a 9-year retrospective real-world evidence study using healthcare databases
por: Cacoub, Patrice, et al.
Publicado: (2020)

Clinical review: Intrapericardial fibrinolysis in management of purulent pericarditis
por: Augustin, Pascal, et al.
Publicado: (2011)

Early use of barbiturates is associated with increased mortality in traumatic brain injury patients from a propensity score-based analysis of a prospective cohort
por: Léger, Maxime, et al.
Publicado: (2022)

Ferroptosis in Liver Diseases: An Overview
por: Capelletti, Martina Maria, et al.
Publicado: (2020)

Iron Metabolism in Normal and Pathological Pregnancies and Fetal Consequences
por: Mégier, Charles, et al.
Publicado: (2022)

Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study
por: Molinari, Nicolas, et al.
Publicado: (2018)

COBI (COntinuous hyperosmolar therapy for traumatic Brain-Injured patients) trial protocol: a multicentre randomised open-label trial with blinded adjudication of primary outcome
por: Roquilly, Antoine, et al.
Publicado: (2017)

Smoking Related Diseases: The Central Role of Monoamine Oxidase
por: Rendu, Francine, et al.
Publicado: (2011)

Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms
por: Uzzan, Mathieu, et al.
Publicado: (2020)

Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
por: Raynor, Alexandre, et al.
Publicado: (2022)

Extrahepatic hepcidin production: The intriguing outcomes of recent years
por: Daher, Raêd, et al.
Publicado: (2019)

Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study
por: Tanaka, Sébastien, et al.
Publicado: (2020)

Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis
por: Augustin, Pascal, et al.
Publicado: (2010)

Prevention of early ventilation-acquired pneumonia (VAP) in comatose brain-injured patients by a single dose of ceftriaxone: PROPHY-VAP study protocol, a multicentre, randomised, double-blind, placebo-controlled trial
por: Dahyot-Fizelier, Claire, et al.
Publicado: (2018)

Relationship between liver dysfunction, lipoprotein concentration and mortality during sepsis
por: Tanaka, Sébastien, et al.
Publicado: (2022)

Impact of continuous hypertonic (NaCl 20%) saline solution on renal outcomes after traumatic brain injury (TBI): a post hoc analysis of the COBI trial
por: Huet, Olivier, et al.
Publicado: (2023)

Regulating Factors of PrP(res) Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains
por: Levavasseur, Etienne, et al.
Publicado: (2008)

Correction: Regulating Factors of PrP(res) Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains
por: Levavasseur, Etienne, et al.
Publicado: (2008)

617. Efficacy of Dimercaptosuccinic Acid (DMSA), a Zinc Chelator, in Combination with Imipenem Against Metallo-β-Lactamase Producing Escherichia coli in a Murine Peritonitis Model
por: Cheminet, Geoffrey, et al.
Publicado: (2019)

Neglected Comorbidity of Chronic Heart Failure: Iron Deficiency
por: Manceau, Hana, et al.
Publicado: (2022)

Atrial fibrillation is not just an artefact in the ICU
por: Seguin, Philippe, et al.
Publicado: (2010)

Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria
por: Mirmiran, Arienne, et al.
Publicado: (2020)

Barbiturate Is Not a Risk Factor For Late Ventilator Associated Pneumonia. a Post-Hoc Analysis On 441 Tbi Patients Included in 2 Rcts
por: Lasocki, S, et al.
Publicado: (2015)

Can pupillometry diagnose a lack of analgesia prior to nursing in critically ill patients?
por: Gaillard, T, et al.
Publicado: (2015)

Association between continuous hyperosmolar therapy and survival in patients with traumatic brain injury – a multicentre prospective cohort study and systematic review
por: Asehnoune, Karim, et al.
Publicado: (2017)

Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain?
por: Hajj, Aline, et al.
Publicado: (2015)

Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family
por: Peoc'h, Katell, et al.
Publicado: (2020)

Circulating Apolipoprotein B-48 as a Biomarker of Parenteral Nutrition Dependence in Adult Patients with Short Bowel Syndrome
por: Fourati, Salma, et al.
Publicado: (2023)

Iron is essential for living!
por: Lasocki, Sigismond, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nmbrilk431ja1g99mvnmd66nji